Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
Key facts
- Where
- Xi'an, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 60 years old?
Source: NCT06082531, who can take part
Where in China
- Xijing hospitalXi'an, ChinaContact: Yanyan JiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Xijing Hospital
- Trial code
- NCT06082531
- Record updated
- 30 July 2026
- Original description
To evaluate the safety and effectiveness of PRP injection therapy in the repair of osteoarthritis and periarticular soft tissue injury through a single-center, exploratory clinical study, and to provide a more reliable basis for the treatment of joint injury.Read full original descriptionShow less
Therapeutic Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis and Periarticular Tissue Injury
To evaluate the safety and effectiveness of PRP injection therapy in the repair of osteoarthritis and periarticular soft tissue injury through a single-center, exploratory clinical study, and to provide a more reliable basis for the treatment of joint injury.
Inclusion: The age range of the participants was 20 to 60 years old. Through a comprehensive clinical and imaging examination, it was conclusively determined that the individuals had knee osteoarthritis or experienced injuries to the cart, and meniscus surrounding the knee joint; The preoperative routine tests and examinations revealed no contraindications; Revised sentence: "Informed consent of the patient.
Exclusion: Prolonged usage of anti-inflammatory drugs and systemic corticoid administration; Patients with tumors or undergoing radiotherapy and chemotherapy; Individuals with mental illnesses who are unable to cooperate with follow-up procedures; The platelet count or function exhibits significant abnormalities、Systemic infection transmitted through the bloodstream; In injection site or damage to the skin; Pregnant or breastfeeding women; Contraindications for MRI、Patients or their families do consent to participate in the study; Other circumstances that render participation in the study unsuitable.